valnoctamide has been researched along with Cytomegalovirus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordey, A; Hsieh, LS; Ornaghi, S; Paidas, MJ; van den Pol, AN; Vergani, P | 1 |
| Davis, JN; Gorres, KL; Miller, G; Ornaghi, S; Paidas, MJ; van den Pol, AN | 1 |
2 other study(ies) available for valnoctamide and Cytomegalovirus Infections
| Article | Year |
|---|---|
Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.
Topics: Amides; Animals; Animals, Newborn; Antiviral Agents; Cognition Disorders; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Encephalitis, Viral; Female; Male; Mice; Mice, Inbred C57BL; Treatment Outcome | 2017 |
Mood stabilizers inhibit cytomegalovirus infection.
Topics: Amides; Animals; Cell Line; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Disease Models, Animal; Female; Humans; Male; Mice; Muromegalovirus; Tranquilizing Agents; Valproic Acid; Viral Load; Virus Replication | 2016 |